Probes Show That PBMs are the Culprits Driving Drug Costs and Overall Spend On the heels of this month’s scathing FTC Interim Staff Report1 on Pharmacy Benefit Managers (PBMs), the House Committee on Oversight and Accountability has released its own official report2 following a years-long investigation into the role played by PBMs, middlemen who negotiate… Read more »
HENDERSON, Nev. – July 9, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, will discuss second quarter 2024 earnings at 5:00 p.m. Eastern time on Wednesday, July 31, 2024. Participant details are as follows: U.S. dial-in:… Read more »
HENDERSON, Nev. – June 20, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced Jeff Baker, Paysign’s Chief Financial Officer, will speak at the Maxim Fintech Virtual Symposium on June 25, 2024, starting at 9:00… Read more »
HENDERSON, Nev. – June 18, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their participation in the iAccess Alpha Buyside Best Ideas Summer Conference, June 25-26, 2024. Jeff Baker, Paysign’s Chief Financial Officer, will… Read more »
HENDERSON, Nev. – June 6, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their participation in the Sidoti Small-Cap Virtual Investor Conference, taking place June 12-13, 2024. Jeff Baker, Paysign’s Chief Financial Officer, will… Read more »
HENDERSON, Nev. – May 7, 2024 – (ACCESSWIRE) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payments processing, today announced financial results for the first quarter 2024. “We are delighted to announce our financial results for the first quarter of 2024. During… Read more »
The Asembia Summit is right around the corner and Paysign is looking forward to attending this annual conference – our Patient Affordability team will be providing insight into Paysign’s dynamic copay solutions, catered specifically around copay accumulator and maximizer mitigation and patient access. To book a meeting, or get more information, visit paysign.com/rx.
Our article, “An Industry Poised for Progress – Bringing Innovation Back to Copay” by Matt Turner, President of Patient Affordability, is featured in PM360, the essential resource for pharmaceutical marketers, April 2024 issue. This Expert on Call article is our third submission, which further explains how the commoditization of copay programs are causing misleading pricing… Read more »
Paysign to be a Sponsor at the Annual Innovative Payments Conference Paysign will be a sponsor at the annual Innovative Payments Conference, “Unlocking the Future of Payments” in Washington, D.C. on May 5-7, 2024. This 3-day conference will consist of revolutionary content, discussions, and networking opportunities with those leading the way in payments compliance, legislation,… Read more »
HENDERSON, Nev. – April 9, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss first quarter 2024 earnings at 5:00 p.m. EDT on Tuesday, May 7, 2024. Participant details are as follows: U.S. dial-in: 877.407.2988… Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.